Questo articolo è stato pubblicato su Diritto24 - Sole 24 ORE. Un’opportunità per fronteggiare le conseguenze socio-economiche della diffusione del Covid-19 è rappresentata dalla possibilità di destinare a tal fine una parte dei fondi europei diretti e indiretti stanziati nel ciclo di programmazione 2014-2020.

Among the many questions the current times have raised is the compelling question of how litigation will be managed. The reaction of the arbitration world to this unprecedented emergency is rather encouraging.

Price gouging cannot constitute per se a breach of the Italian Consumer Code, but it may raise the standard of diligence to discharge firms’ information obligations and aggravate a separate misleading conduct

AGCOM issued an unprecedented six-month suspension for two television broadcasters for hosting Mr. Panzironi’s program which could induce consumers to underestimate the risks of COVID-19

Il Decreto Liquidità ha sospeso l'applicazione di alcune disposizioni della legge sull'insolvenza per impedire agli operatori economici di liquidare le loro attività o di incorrere in procedure concorsuali a causa di COVID-19.

The European Commission adopted a proposal to postpone the date of application of Medical Device Regulation by one year and deviate from the conformity assessment procedures in cases of emergency.

On April 7, 2020, the Italian Medicines Agency (“AIFA”) provided guidance on the management of clinical trials in light of the restrictive measures adopted by the Government against the COVID-19 pandemic.

Breaking news about e-prescriptions: Ordinance 651/2020 and Ministerial Decree of March 25, 2020 introduced alternative tools to paper memorandum of e-prescriptions.

To address the current emergency caused by COVID-19, several initiatives have been undertaken at the regulatory level to promote and facilitate clinical trials and early access to drugs.